Exposure, Relaxation, & Rescripting Therapy-Child
| Status: | Completed |
|---|---|
| Conditions: | Insomnia Sleep Studies, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 5 - 17 |
| Updated: | 11/16/2018 |
| Start Date: | October 2012 |
| End Date: | November 2016 |
Untreated trauma-related nightmares and sleep-related disorders are associated with chronic
health problems, burdening both the suffering individual and the health-care system. The
study implements an innovative, cost-efficient, nightmare treatment for trauma-exposed
children. It is the first randomized clinical trial with children, adapting an efficacious
adult therapy to a 5-session nightmare treatment for 5-17 year-olds. Trauma nightmares are a
mechanism in development and maintenance of secondary post-trauma psychopathology, medical
problems and family dysfunction. Therefore, this treatment may prevent long-term secondary
health and behavioral problems. It provides a viable healthcare option to Oklahomans,
lessening long-term financial medical and behavioral health expenses. Scientific models
currently view PTSD treatment as primary, often leaving nightmares untreated. That approach
does not address the pernicious impact of trauma-nightmares in individuals with sub-threshold
PTSD or whose nightmares are a primary condition. The theoretical innovation of this therapy
can advance the field's understanding of the development of trauma sequelae.
health problems, burdening both the suffering individual and the health-care system. The
study implements an innovative, cost-efficient, nightmare treatment for trauma-exposed
children. It is the first randomized clinical trial with children, adapting an efficacious
adult therapy to a 5-session nightmare treatment for 5-17 year-olds. Trauma nightmares are a
mechanism in development and maintenance of secondary post-trauma psychopathology, medical
problems and family dysfunction. Therefore, this treatment may prevent long-term secondary
health and behavioral problems. It provides a viable healthcare option to Oklahomans,
lessening long-term financial medical and behavioral health expenses. Scientific models
currently view PTSD treatment as primary, often leaving nightmares untreated. That approach
does not address the pernicious impact of trauma-nightmares in individuals with sub-threshold
PTSD or whose nightmares are a primary condition. The theoretical innovation of this therapy
can advance the field's understanding of the development of trauma sequelae.
Inclusion Criteria:
- children age 5-17 with traumatic or potentially traumatic/adverse experiences and
nightmares occurring at least once per week over a minimum of one month
- have a parent or legal guardian who is able to participate in treatment assignments at
home and be able to read and speak English
Exclusion Criteria:
- adult, no traumatic experience, no nightmares, apparent psychosis, pervasive
developmental disorder, or mental retardation, not able to read and speak English
- in order to ensure the verbal comprehension of the child, the PPVT will be used to
help evaluate if a child is suitable for treatment, as an index to ensure they can
verbally comprehend the cognitive component of treatment
We found this trial at
1
site
Tulsa, Oklahoma 74104
Principal Investigator: Lisa Cromer, Phd
Phone: 918-631-2543
Click here to add this to my saved trials
